Company intelligence / Profile preview

Sustainable Bioresources

The Woodlands, Texas, United States

Ownership: Private
Development stage: Other

Overview

Sustainable Bioresources is a biotechnology company focused on the sustainable production of high-value plant-derived compounds, specifically taxanes like Paclitaxel (Taxol). The company utilizes proprietary plant cell culture technology and sustainable harvesting methods to provide a reliable supply of pharmaceutical precursors and active ingredients. By reducing reliance on wild-harvested biomass, they address environmental concerns while ensuring consistent quality for the oncology market. Their expertise spans from botanical sourcing to advanced extraction and purification processes, supporting the global supply chain for critical chemotherapy agents.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Sustainable Bioresources.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sustainable Bioresources.

Explore the full profile